IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.601
EU - Europa 6.178
AS - Asia 1.174
AF - Africa 20
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AN - Antartide 1
Totale 14.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.554
GB - Regno Unito 1.391
IE - Irlanda 1.193
IT - Italia 937
CN - Cina 691
SE - Svezia 639
UA - Ucraina 509
RU - Federazione Russa 463
DE - Germania 323
FR - Francia 296
SG - Singapore 257
FI - Finlandia 247
VN - Vietnam 123
CA - Canada 40
ES - Italia 34
IN - India 33
BE - Belgio 31
CZ - Repubblica Ceca 17
NL - Olanda 17
PL - Polonia 17
CI - Costa d'Avorio 14
TR - Turchia 14
IR - Iran 12
EU - Europa 9
GR - Grecia 8
HK - Hong Kong 8
LT - Lituania 8
CH - Svizzera 7
DK - Danimarca 6
JP - Giappone 6
AT - Austria 5
IQ - Iraq 5
AU - Australia 4
BO - Bolivia 4
EG - Egitto 4
NO - Norvegia 4
AR - Argentina 3
BG - Bulgaria 3
BR - Brasile 3
CL - Cile 3
IL - Israele 3
MT - Malta 3
MX - Messico 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CO - Colombia 2
EE - Estonia 2
ID - Indonesia 2
MK - Macedonia 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
PH - Filippine 1
TM - Turkmenistan 1
Totale 14.007
Salva come PNG Salva come JPEG
Città #
Southend 1.208
Dublin 1.188
Fairfield 889
Chandler 679
Ashburn 551
Santa Clara 484
Jacksonville 418
Woodbridge 399
Siena 363
Seattle 325
Houston 316
Wilmington 313
Cambridge 296
Ann Arbor 246
Princeton 199
Singapore 197
Beijing 165
Nanjing 135
Dong Ket 121
Helsinki 111
New York 87
San Mateo 73
Boardman 64
San Diego 62
Lappeenranta 58
Shanghai 57
Lancaster 56
Florence 54
Shenyang 50
Menlo Park 48
Nanchang 42
Moscow 37
Rome 36
Munich 31
Dearborn 30
Brussels 29
Málaga 27
Tianjin 26
London 25
Hebei 23
Kunming 23
Milan 23
Washington 23
Jiaxing 22
Fremont 20
Los Angeles 20
San Francisco 19
Toronto 19
Norwalk 16
Redwood City 15
Abidjan 14
Jinan 13
Brno 12
Lastra a Signa 12
Zhengzhou 12
Guangzhou 11
Changsha 10
Piscataway 10
Agliana 9
Ottawa 9
Poggibonsi 9
Clifton 8
Düsseldorf 8
Frankfurt am Main 8
Hangzhou 8
Montreal 8
Phoenix 8
Chicago 7
Izmir 7
Monteriggioni 7
Ningbo 7
Bacoli 6
Falls Church 6
Mestre 6
Nuremberg 6
Redmond 6
Taizhou 6
Baghdad 5
Baronissi 5
Bolsena 5
Changchun 5
Columbus 5
Copenhagen 5
Dallas 5
Gurugram 5
Hefei 5
Hounslow 5
Kilburn 5
Saint Louis 5
Slough 5
Tokyo 5
Venezia 5
Vienna 5
Amsterdam 4
Bangalore 4
Barolo 4
Cairo 4
Figline Valdarno 4
Gdynia 4
Lanciano 4
Totale 10.059
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 238
Vaginal immunization to elicit primary T-cell activation and dissemination 237
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 229
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 207
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 204
Modulation of Primary Immune Response by Different Vaccine Adjuvants 193
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 185
Identification of a branching process model for adaptive immune response 177
Role of the microbiota in the modulation of vaccine immune responses 177
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 174
Correlates of vaccine-induced protective immunity against Ebola virus disease 173
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 173
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 172
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 171
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 171
Ebola vaccine R&D: Filling the knowledge gaps 170
Big science for vaccine development 166
Vaccination in the elderly: The challenge of immune changes with aging 162
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 161
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 161
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 154
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 150
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 149
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 145
Adoptive transfer of transgenic T cells to study mucosal adjuvants 144
The European research effort for HIV/AIDS, malaria and tuberculosis 142
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 140
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 139
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 139
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 136
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 135
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 135
Assessment of mucosal immunity to HIV-1 134
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 134
Vaccine adjuvants: A priority for vaccine research 131
null 131
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 131
ADITEC: joining forces for next-generation vaccines 131
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 129
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 129
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 128
Gram-positive commensal bacteria for mucosal vaccine delivery. 128
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 127
Biotechnological approaches to fight pathogens at mucosal sites 127
Innate immunity against HIV: a priority target for HIV prevention research 126
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 125
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 125
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 123
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 121
Surface display of recombinant proteins on Bacillus subtilis spores 121
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 121
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 120
Vaginal immunization with recombinant gram-positive bacteria 115
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. 113
Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery. 113
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 112
The European effort towards the development of mucosal vaccines for poverty-related diseases 110
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 105
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities 105
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization 104
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 104
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors 104
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 104
null 102
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 102
Recombinant Streptococcus gordonii as a mucosal vaccine vector 98
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 98
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 97
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 96
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 95
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 95
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 94
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 93
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 91
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 90
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 89
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 89
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 89
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 87
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 87
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 86
Primary T-cell response to mucosal vaccination 86
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 85
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 83
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 82
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 82
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 82
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 82
NMR investigation of the simultaneous fermentation of xylose and glucose by a selected strain of Klebsiella planticola (G11) 81
Mucosal vaccine delivery in the female genital tract by recombinant Gram-positive bacteria 81
Expression of measles virus antigens in Streptococcus gordonii 81
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 81
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 81
NMR investigation of the simultaneous fermentation of xylose and glucose by a selected strain of Klebsiella planticola (G11) 77
Secretion of heterologous proteins in Streptococcus gordonii (Streptococcus sanguis) Challis. 76
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 76
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 74
Oral priming of mice using recombinant spores of Bacillus subtilis 73
Cross talk among bacteria and dendritic cells 73
Mucosal adjuvants 72
Totale 12.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.323 0 0 0 0 0 195 196 301 172 239 77 143
2020/20211.990 75 199 50 160 105 192 83 253 236 253 175 209
2021/20221.596 117 226 98 159 64 27 85 53 84 143 184 356
2022/20232.363 147 238 319 306 213 466 61 206 182 49 119 57
2023/20242.030 73 67 160 118 79 518 668 65 43 87 35 117
2024/20251.772 129 179 429 249 536 250 0 0 0 0 0 0
Totale 14.270